SAB Biotherapeutics Inc.
3.48
-0.07 (-1.97%)
At close: Jan 15, 2025, 3:59 PM

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 56.57M 15.05M 33.21M 12.61M 6.35M
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets 350.23K 467.69K n/a n/a n/a
Receivables n/a 5.56M 8.01M 20.57M 2.82M
Inventory n/a n/a n/a n/a n/a
Other Current Assets 2.34M 1.49M 8.97M 1.28M 124.00K
Total Current Assets 58.91M 22.10M 48.42M 34.46M 9.29M
Property-Plant & Equipment 24.68M 28.34M 30.95M 22.08M 8.71M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 25.03M 28.81M 30.95M 22.08M 8.71M
Total Assets 83.94M 50.90M 79.37M 56.54M 18.00M
Account Payables 945.93K 3.68M 4.46M 7.38M 2.17M
Deferred Revenue 1.32M n/a 100.00K 100.00K n/a
Short-Term Debt 1.85M 2.02M 3.10M 1.66M 1.95M
Other Current Liabilities 6.65M 9.24M 16.81M 1.92M -4.12M
Total Current Liabilities 10.81M 14.99M 24.68M 11.06M 4.62M
Long-Term Debt 4.05M 4.53M 5.42M 6.47M 53.45K
Other Long-Term Liabilities 11.77M 320.93K 10.72M n/a 15.64M
Total Long-Term Liabilities 15.83M 4.85M 16.14M 6.47M 15.69M
Total Liabilities 26.64M 19.85M 40.82M 17.53M 20.31M
Total Debt 5.91M 5.93M 6.74M 8.13M 7.64M
Common Stock 929.00 5.09K 4.35K 3.52K 3.52K
Retained Earnings -90.06M -47.87M -29.13M -11.98M -32.10M
Comprehensive Income 26.42K n/a n/a n/a n/a
Shareholders Equity 57.30M 31.06M 38.55M 39.01M -2.31M
Total Investments n/a n/a n/a n/a n/a

Create Price Alert on SABS

Your price alert will notify you when the stock price is above 3.48.

Add to Watchlist